36584011000001109: Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)
\UK product\Virtual medicinal product\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)
\UK product\Virtual therapeutic moiety\Infliximab\Product containing only infliximab in parenteral dose form (medicinal product form)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)
\UK product\Virtual therapeutic moiety\Infliximab\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)
\UK product\Trade family\Zessly\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing tumor necrosis factor alpha inhibitor\Product containing infliximab\Infliximab\Product containing only infliximab in parenteral dose form (medicinal product form)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing tumor necrosis factor alpha inhibitor\Product containing infliximab\Infliximab\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing tumor necrosis factor alpha inhibitor\Product containing infliximab\Product containing infliximab in parenteral dose form (medicinal product form)\Product containing only infliximab in parenteral dose form (medicinal product form)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Product containing infliximab\Infliximab\Product containing only infliximab in parenteral dose form (medicinal product form)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Product containing infliximab\Infliximab\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Product containing infliximab\Product containing infliximab in parenteral dose form (medicinal product form)\Product containing only infliximab in parenteral dose form (medicinal product form)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)
\Medicinal product\Product manufactured as parenteral dose form\Product containing infliximab in parenteral dose form (medicinal product form)\Product containing only infliximab in parenteral dose form (medicinal product form)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection\Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

112415401000001118 Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

112415501000001119 Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator	EMA (European Medicines Agency) monitoring	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Is a	Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has manufactured dose form	Powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has basis of strength substance	Infliximab	true	Inferred relationship	Existential restriction modifier	1
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has presentation strength numerator value	100	false	Inferred relationship	Existential restriction modifier	1
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has presentation strength denominator unit	Vial	true	Inferred relationship	Existential restriction modifier	1
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has precise active ingredient	Infliximab	true	Inferred relationship	Existential restriction modifier	1
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has unit of presentation	Vial	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	VMP prescribing status (attribute)	VMP not recommended to prescribe - brands not bioequivalent	false	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has specific active ingredient	Infliximab	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has dispensed dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Is a	Zessly	true	Inferred relationship	Existential restriction modifier
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	VMP prescribing status (attribute)	Caution - AMP level prescribing advised	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) 1 vial	Has AMP	True	Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
112415401000001118	Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
112415501000001119	Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module